T1	Participants 678 726	60 newly diagnosed stage 1 hypertensive patients
T2	Participants 763 771	patients
T3	Participants 799 813	nebivolol 5 mg
T4	Participants 875 893	d valsartan 160 mg
T5	Participants 962 970	patients
T6	Participants 1285 1296	both groups
T7	Participants 1485 1497	both groups.
